G protein-coupled receptors (GPCRs) are essential in regulating various physiological processes and have emerged as key therapeutic targets for diseases such as obesity and diabetes. Here, we present bioluminescence tools for monitoring GPCR dynamics. These tools include NanoBRET® cellular target engagement assay for characterizing ligand binding, HiBiT tagging for tracking receptor internalization, kinetic live-cell assays for β- arrestin recruitment, and technologies for real-time and high-throughput monitoring of cAMP. Additionally, ligand potency can be effectively ranked using ready-to-use bioluminescence bioassays. These innovations offer significant improvements in high-throughput screening of GPCR-targeting ligands, providing detailed insights into their pharmacology. Together, these technologies form an integrated platform — from initial ligand engagement to functional downstream signaling — that accelerates the pharmacological characterization needed to advance the next generation of metabolic disease therapeutics.
